Franklin Resources Inc Atea Pharmaceuticals, Inc. Transaction History

Franklin Resources Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$3.21 - $5.06 $181,236 - $285,687	56,460 New	56,460 $211,000
Q2 2022 Aug 11, 2022	SELL	$5.33 - $8.18 $123,330 - $189,277	-23,139 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$7.67 - $44.59 $219,822 - $1.28 Million	-28,660 Reduced 55.33%	23,139 $207,000
Q3 2021 Nov 12, 2021	BUY	$21.33 - $35.06 $1.1 Million - $1.82 Million	51,799 New	51,799 $1.82 Million

112

52.4M

900

126K

Ticker AVIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,258,600
Market Cap $272M
Description
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.